Predicting Ventricular Arrhythmias in Cardiac Resynchronization Therapy: The Impact of Persistent Electrical Dyssynchrony

Pacing Clin Electrophysiol. 2016 Sep;39(9):969-77. doi: 10.1111/pace.12908. Epub 2016 Jul 23.

Abstract

Background: Although response to cardiac resynchronization therapy (CRT) has been conventionally assessed with left ventricular volume reduction, ventricular arrhythmias (ventricular tachycardia/ventricular fibrillation [VT/VF]) are of critical importance associated with unfavorable outcomes even in the "superresponders" to therapy. We evaluated the predictors of VT/VF and the association of residual dyssynchrony during follow-up.

Methods: Ninety-five patients receiving CRT were followed-up for 9 ± 3 months. Post-CRT dyssynchrony was defined as a prolonged QRS duration (QRSd) for persistent electrical dyssynchrony (ED), and a Yu index ≥ 33 ms for persistent mechanical dyssynchrony. The first VT/VF episode, including nonsustained VT detected on device interrogation and/or appropriate antitachycardia pacing or shock for VT/VF, were the end points of the study.

Results: Forty-five patients who reached the study end points had significantly lower mean ΔQRS (baseline QRSd - post-CRT QRSd) values than those without VT/VF (-20.8 ± 28.9 ms vs -6.6 ± 30.7 ms, P = 0.022). Both the baseline and post-CRT QRSds, along with the Yu index values, were not different in two groups. Patients with VT/VF were statistically more likely to have persistent ED (38% vs 9%, P = 0.021). Kaplan-Meier curves showed that a negative ΔQRS was associated with a higher incidence of VT/VF during follow-up (P = 0.016). A multivariate Cox model revealed that QRS prolongation was an independent predictor of VT/VF after CRT (P = 0.029).

Conclusions: A negative ΔQRS, also called persistent ED, is associated with VT/VF. Narrowest possible QRSd might be a reliable goal of both implantation and optimization of devices to reduce arrhythmic events after CRT.

Keywords: QRS duration; cardiac resynchronization therapy; electrical dyssynchrony; mechanical dyssynchrony; ventricular arrhythmia.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Cardiac Resynchronization Therapy / methods*
  • Electrocardiography / methods*
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care / methods
  • Prognosis
  • Recurrence
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tachycardia, Ventricular / diagnosis*
  • Tachycardia, Ventricular / therapy*
  • Treatment Outcome
  • Ventricular Fibrillation / diagnosis*
  • Ventricular Fibrillation / therapy*